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Gianotti–Crosti Syndrome is an idiopathic nonspeciﬁc cutaneous host response. It manifests as a benign papular rash classically lim-
ited to the extremities and the face.
We are reporting a case of an eighteen-month-old healthy boy presented with an itchy papular rash of one week duration, two days
following vaccinations.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Gianotti–Crosti Syndrome is a unique (Fastenberg and
Morrell, 2007) self-limiting (Chiriac et al., 2011) papular
rash typically conﬁned to the extremities, buttocks and
face. It was ﬁrst described by Ferdinando Gianotti in
1955 and then by both, Gianotti and Crosti, in 1957
(Chuh, 2014). Up to date, around 300 cases were reported
in the medical literature, twenty-one of which were attrib-
uted to preceding vaccinations.
We aimed to report such a rare case of an infant pre-
sented with a sudden onset of extensive progressive papular
eruption after routine childhood vaccinations. We followed
the case report with a literature review.http://dx.doi.org/10.1016/j.jdds.2015.05.001
2352-2410/ 2015 The Authors. Production and hosting by Elsevier B.V. on b
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Production and hosting by Elsevier2. The case
An eighteen-month-old healthy boy presented with an
abrupt onset of itchy skin-coloured pimples that started
on his legs, upper limbs and the perioral area over one
week duration. The rash appeared two days following his
ﬁrst booster of Oral Polio Vaccine, Pentavalent Vaccine
[Diphtheria, Pertussis and Tetanus (DPT), Hepatitis B
and Haemophilus Inﬂuenza type b] and his ﬁrst dose of
Hepatitis A Vaccine.
Themother denied any history of fever, contact with cases
of similar symptoms and family history of atopy. The rash
showed minimal response to Betamethasone cream and
Cetirizine as prescribed by his family physician seen in the
local health centre. A week later, the eruption extended to
involve his buttocks, thighs, palms, soles and lateral sides
of his abdomen. Scalp, oral cavity, and chest were spared.
Mother was self-medicating her child with seawater immer-
sion which resulted in pealing of palms of hands.
On examination, there were symmetrically distributed
monomorphic skin-coloured papules on the extensor sur-
faces of upper and lower limbs extending to the palms,ehalf of King Saud University.
commons.org/licenses/by-nc-nd/4.0/).
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ations over the lower extremities, see Fig. 1. Examination
of lymph nodes and abdomen was unremarkable. In the
follow up, we noticed papulosquamous eruption of palms
and excoriations over the gluteal region, see Fig. 2.
The temporal relationship between the recent vaccina-
tions and this rash guided us towards the diagnosis of
Gianotti–Crosti Syndrome. To rule out possible patholog-
ical aetiologies, we investigated the patient for EBV anti-
bodies, CMV antibodies, HIV antibodies, parvovirus B19
antibodies, mycoplasma pneumonia antibodies, and viral
hepatitis. Serology was negative.
Management wise, we reassured the mother, and started
the patient on Crotamiton cream 10% twice daily for two
weeks and Chlorpheniramine 0.3 milligram kilogram1
along with a moisturizing lotion. The rash showed sponta-
neous resolution in six weeks duration.3. Discussion
Gianotti–Crosti Syndrome peaks in children below the
age of four years; yet, it can aﬀect children aged from three
months to ﬁfteen years (Chiriac et al., 2011) with an equal
distribution across males and females (Chuh, 2014).
Though it is rare, some cases reported adulthoodFig. 1. Skin-coloured papules on the extensor surface of the: (A) Right
upper limb; and (B) Right knee with excoriation.
Fig. 2. After seawater immersion: (A) Desquamation of the right palmpresentation (Wu, 2009; Manoharan et al., 2005;
Cambiaghi et al., 1995), with female predomination
(Chuh, 2014).
Gianotti–Crosti Syndrome was initially linked to hepati-
tis B infection subtype AYW (Erkek et al., 2001). However,
negative hepatitis B serology in multiple cases diagnosed
with Gianotti–Crosti Syndrome suggests other possible
immunological triggers. Epstein–Barr virus is the most
common associated infection worldwide. Other infectious
triggers can be viral: hepatitis A virus, cytomegalovirus,
coxsackievirus, respiratory syncytial virus, parainﬂuenza
virus, rotavirus, mumps, parvovirus and molluscum conta-
giosum; or bacterial: Bartonella henselae, Mycoplasma
pneumoniae, and group A streptococci. Where a speciﬁc
infection was absent, some reports documented other asso-
ciations like atopy and vaccination (Wu, 2009), see Table 1.
Our patient received multiple vaccines at a time; this makes
it diﬃcult to attribute such a presentation to a single vacci-
nation. Given the fact that all other received vaccinations
were actually boosters with a negative history of associated
reactions; hepatitis A vaccine might be responsible for this
rash. This is consistent with Sigmon et al. (2012), Kolivras
and Andre´ (2008) and Metelitsa and Fiorllo (2011). Yet,
type IV hypersensitivity reaction cannot be excluded, given
the 48-h timeframe of rash development.
Although rash appears as a group of small, often
non-pruritic, ﬂat-topped papules or papulovesicles of sud-
den onset in a previously healthy child; pruritus was reported
in certain cases. Papules are typically ﬂesh or skin-coloured,
coppery red, or pale pink with a tendency of being darker on
legs or in severe cases. On sites of trauma, papules appear
coalesced with mild scales. Hands, wrists and buttocks are
the most common sites of eruption followed by limbs and
face. Trunk involvement is rare; yet it is reported (Chuh,
2003). Oral mucosa, palms and soles are typically spared
(Wu, 2009) even though; our patient presentedwith eruption
involving rare areas: palms, soles and parts of the abdomen.
This rash is self-limiting with an expected spontaneous
recovery in six weeks (Magyarlaki et al., 1991); however, late
remission may occur in 6–12 months (Chuh, 2014).
Gianotti–Crosti Syndrome has a non-relapsing course;
though, recurrence was documented in one case (Metelitsa
and Fiorllo, 2011). Eruption can be accompanied by fever,; and (B) papular rash with excoriations over the gluteal region.
Table 1
Reported cases of Gianotti–Crosti Syndrome in association with vaccination.
Report Clinical presentation Age Vaccination Interval
in days
Retrouvey et al. (2012) Asymmetrically distributed pink papules
which coalesced into plaques+ post
vaccination fever
19 months DTaP and varicella zoster virus live 2
Sigmon et al. (2012) – – Hepatitis A and inﬂuenza –
Kwon et al. (2011) – – H1N1 –
Lam (2011) – – H1N1 –
Kroeskop et al. (2011) Symmetrically distributed ﬂat-topped ﬂesh-
coloured papules and papulovesicles
9 years H1N1 4
Atanasovski et al. (2011) Monomorphic papules 15 months MMR and DTaP 2
Kolivras and Andre´ (2008) Symmetrical papular eruption 18 months Hepatitis A 14
Monastirli et al. (2007) Flesh-coloured ﬁrm 2–4 mm papules and
papulovesicles
3 years Hepatitis A 3
Karakas et al. (2007) A slightly pruritic skin eruption 5 years Hepatitis B 21
Schwerk et al. (2005) – Infant Poliomyelitis, DTPa, Hib, Hepatitis B and
Strep. pneumoniae
5
Kang and Oh (2003) Rash 3 years Japanese B Encephalitis 1
Andiran et al. (2002) Rash 11 months Measles and the third dose of Hepatitis B 14
Haug et al. (2002) – Four infants – 4–6
Erkek et al. (2001) Papules and lymphadenopathy 4 years Polio Vaccine and Varicella Infection 4
Murphy and Buckley (2000) Flesh-coloured papules in acral distribution 6 months DPT, Oral Polio, Hib 24
Velangi and Tidman (1998) Non-pruritic papules 15 months MMR 3
Lacour and Harms (1995) – – – –
Cambiaghi et al. (1995) – Adult Inﬂuenza –
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2009).
Histopathologically, ﬁndings are typically unspeciﬁc:
spongiosis, hyperkeratosis, subepidermal inﬁltration of
lymphocytes, monocytes and histocytes and deep dermal
perivascular inﬂammation (Magyarlaki et al., 1991).
Gianotti–Crosti Syndrome is self-limiting. Supportive
measures are taken in symptomatic presentations. For pru-
ritus, topical medications like emollients and calamine
lotion are suﬃcient. Sedative antihistamines can be added
if needed. Parental education is important; aetiology and
prognosis should be discussed. In cases associated with
viral infections; especially hepatitis B virus, monitoring is
essential (Chuh, 2014).
What makes this case unique is ﬁrstly the pruritic nature
and the unusual distribution of the eruption with palms,
soles and trunk involvement- which, to the best of our
knowledge, was never reported; secondly the development
of this syndrome post-vaccinations; and thirdly having this
case reported from Bahrain as ﬁrst documentation in the
medical literature.
4. Conclusion
Gianotti–Crosti Syndrome following vaccine is rare. We
reported a case of Gianotti–Crosti Syndrome with unusual
symptomatic distribution of rash following vaccinations.
Spontaneous remission occurred within six weeks.
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